Carlsbad, CA, United States of America

Jens Harborth

USPTO Granted Patents = 12 

 

 

Average Co-Inventor Count = 6.5

ph-index = 4

Forward Citations = 29(Granted Patents)


Location History:

  • Boston, MA (US) (2011 - 2015)
  • Carlsbad, CA (US) (2017 - 2023)
  • San Diego, CA (US) (2019 - 2024)

Company Filing History:


Years Active: 2011-2024

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Jens Harborth: Innovator in Genetic Research

Introduction

Jens Harborth is a prominent inventor based in Boston, MA, renowned for his significant contributions to genetic research. With two patents to his name, he has made strides in the field of biotechnology, particularly in the inhibition of gene expression.

Latest Patents

Jens Harborth's latest patents focus on "Compositions and methods for inhibiting expression of the IKK-B gene." This invention pertains to a double-stranded ribonucleic acid (dsRNA) designed to inhibit the expression of the IKK-B gene. The dsRNA includes an antisense strand with a nucleotide sequence of less than 30 nucleotides, typically ranging from 19 to 25 nucleotides, which is substantially complementary to parts of the IKK-B gene. The invention also encompasses a pharmaceutical composition containing this dsRNA along with a pharmaceutically acceptable carrier. Moreover, it introduces methods for treating diseases associated with the expression or activation of the IKK-B gene, as well as methods for inhibiting the gene's expression in a cell.

Career Highlights

Throughout his career, Jens Harborth has contributed extensively to biotechnology and genetic innovation. He has worked at Alnylam Pharmaceuticals, Inc., a leader in RNA interference therapeutics, and at the Imperial College of Science, Technology and Medicine, where he has engaged in groundbreaking research that advances our understanding of gene regulation.

Collaborations

Jens has collaborated with notable colleagues in his field, including Antonin de Fougerolles and Andrew Sprague. These collaborations have enriched his research endeavors and allowed for the sharing of knowledge and expertise in genetic engineering.

Conclusion

With a focus on innovative genetic therapies, Jens Harborth stands out as a key inventor in his field. His patents not only reflect his commitment to scientific advancement but also hold the potential for significant impact on therapeutic strategies for diseases linked to the IKK-B gene. His ongoing work continues to inspire future innovations in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…